Interestingly, an increase in the concentration of plasma serum albumin resulted in a decrease in the CDDP-derived hydrolysis products, suggesting that reinforcement of the plasma albumin concentration in cancer patients prior to CDDP treatment could be a simple strategy for alleviation of CDDP-induced toxic side effects. Here, ALB is linked to cancer.